MedPath

Screening methods of cervical cancer- A comparative analysis

Not Applicable
Completed
Conditions
Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Registration Number
CTRI/2020/08/027023
Lead Sponsor
Gajra Raja Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
500
Inclusion Criteria

All sexually active women and women in reproductive age group with recurrent episodes of white discharge, postcoital bleeding and intermenstrual bleeding.

Exclusion Criteria

Women who refused to give consent and known cases of cervical carcinoma, pregnant women, women with active vaginal bleeding

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
For women who are devoid of any screening test, VIA based screenng will be a good screening tool.Timepoint: At the end of the study (i.e, 1 year)
Secondary Outcome Measures
NameTimeMethod
To calculate the sensitivity and specificity of VIA screeing of carcinoma cervix.Timepoint: At the end of the study (i.e, 1 year)
© Copyright 2025. All Rights Reserved by MedPath